Valor Intrínseco del S&P y Nasdaq Contáctenos
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Volver a todas las acciones

Greenwich LifeSciences, Inc. GLSI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$50.00
+93%

Ha habido 50 transacciones internas recientes registradas para Greenwich LifeSciences, Inc. (GLSI), incluyendo 50 compras y 0 ventas. El total de compras internas fue valorado en $24.19M y el total de ventas internas en RSU Award.

Internos destacados con actividad reciente incluyen Patel Snehal, Mcwilliams David, Thompson Jaye. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — GLSI

Fecha Nombre Cargo Tipo de Transacción Acciones Precio Promedio Valor Acciones en Propiedad
2026-01-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,800 $29.83 $53.69K 5,604,102
2026-01-12 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,900 $27.54 $79.87K 5,602,302
2025-12-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 4,300 $21.36 $91.85K 5,599,402
2025-12-30 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,900 $21.73 $63.02K 5,595,102
2025-12-18 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 4,100 $12.62 $51.74K 5,592,202
2025-11-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 4,600 $8.37 $38.5K 5,588,102
2025-11-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Concesión de RSU 100,000 $8.20 $820K 2,347,462
2025-11-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 10,600 $8.43 $89.36K 5,583,502
2025-10-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,300 $9.26 $21.3K 5,572,902
2025-04-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,600 $9.88 $35.57K 5,570,602
2025-04-17 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 5,400 $8.98 $48.49K 5,567,002
2025-04-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,600 $9.10 $32.76K 5,561,602
2025-04-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 5,500 $8.73 $48.02K 5,558,002
2025-01-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,500 $12.51 $31.28K 5,552,502
2025-01-07 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,800 $13.75 $24.75K 5,550,002
2025-01-06 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,100 $13.31 $14.64K 5,548,202
2025-01-03 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,400 $12.95 $44.03K 5,547,102
2025-01-02 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,000 $11.97 $23.94K 5,543,702
2024-12-31 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,400 $11.36 $27.26K 5,541,702
2024-12-30 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,200 $11.12 $35.58K 5,539,302
2024-12-24 Mcwilliams David Director Concesión de RSU 61,984 $12.16 $753.73K 123,968
2024-12-24 Thompson Jaye VP Clinical Reg Affairs Concesión de RSU 149,818 $12.16 $1.82M 299,636
2024-12-24 Daugherty Frank Joseph Chief Medical Officer Concesión de RSU 104,890 $12.16 $1.28M 209,780
2024-12-24 Rothe Eric Director Concesión de RSU 41,349 $12.16 $502.8K 82,698
2024-12-24 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Concesión de RSU 1,148,723 $12.16 $13.97M 2,222,454
2024-12-24 Hallock Kenneth Director Concesión de RSU 41,349 $12.16 $502.8K 82,698
2024-11-21 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 1,000 $12.91 $12.91K 264,148
2024-09-26 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,500 $14.63 $21.95K 5,536,102
2024-08-12 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 800 $13.85 $11.08K 263,148
2024-08-06 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,000 $13.81 $27.62K 5,534,602
2024-08-05 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 5,500 $13.18 $72.49K 5,532,602
2024-08-02 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 1,000 $15.15 $15.15K 262,348
2024-07-23 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,500 $15.89 $23.84K 5,527,102
2024-07-18 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 1,000 $16.00 $16K 261,348
2024-06-13 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 174,825 $14.30 $2.5M 5,525,602
2024-04-01 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,000 $19.08 $57.24K 5,350,777
2024-03-22 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,500 $19.98 $49.95K 5,347,777
2024-03-20 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,500 $17.68 $26.52K 5,345,277
2024-03-05 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 30,500 $12.49 $380.95K 5,343,777
2024-03-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 4,100 $13.03 $53.42K 5,340,277
2024-02-16 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 10,800 $11.16 $120.53K 5,336,177
2024-02-15 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 12,700 $11.07 $140.59K 5,325,377
2023-11-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 5,000 $10.17 $50.84K 5,312,677
2023-11-03 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 3,500 $9.11 $31.89K 5,307,677
2023-10-27 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 500 $8.57 $4.29K 260,348
2023-10-26 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,500 $7.97 $19.93K 5,304,177
2023-10-25 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,500 $7.91 $19.78K 5,301,677
2023-10-10 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 1,000 $9.07 $9.07K 5,299,177
2023-10-04 Patel Snehal 10 Percent Owner, Officer: CEO and CFO Compra Informativa 2,000 $8.63 $17.26K 5,298,177
2023-09-26 Thompson Jaye VP Clinical Reg Affairs Compra Informativa 600 $8.71 $5.23K 259,848
■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento

Otros también ven

TERN
TERN
Terns Pharmaceuticals, Inc.
$52.71
+0.06%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.47
+0.05%
 AMLX
AMLX
Amylyx Pharmaceuticals, Inc.
$17.12
+1.18%
 AVXL
AVXL
Anavex Life Sciences Corp.
$3.24
+3.85%
 INZY
INZY
Inozyme Pharma, Inc.
$4.00
+0.25%
 ABOS
ABOS
Acumen Pharmaceuticals, Inc.
$2.72
+1.49%
 IMMP
IMMP
Immutep Limited
$0.54
+72.81%
 PDSB
PDSB
PDS Biotechnology Corporation
$1.36
+28.30%
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
📧 [email protected]
📞 +65 8912 8000
Envíanos un mensaje